A study using TIGIT and PD-1 drugs for gastrointestinal disease was canceled for “futility” at an early checkpoint, another blow to research on a once-promising target.
Continue reading →
“Collaborative discussions” with the FDA encouraged Praxis to submit early next year an approval filing for its epilepsy drug. Elsewhere, Rezolute shares plunged and Centessa announced a new CEO.
Continue reading →
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington...
David Garza a veces siente que no tiene seguro médico, por lo caro que le cuesta tratar su diabetes tipo 2. Su prima mensual de $435 por la cobertura familiar es casi igual a la del seguro de su trabajo anterior. Pero el plan de salud de su empleo actual tiene un deducible anual de $4.000,...
Maersk today announced a raft of changes across senior leadership as rival carriers challenge its dominance in global logistics. Maersk parent A.P. Moller-Maersk said that former Kuehne & Nagel executive Robert Erni has joined the company as chief financial officer and member of the...
A federal audit has found that New York State is routinely issuing unlawful or illegal commercial driver’s licenses – which are valid for up to eight years – to foreign applicants with expired visas or work authorizations. The audit, conducted by the Federal Motor Carrier Safety Administration,...